Future of drugs-Heart Disease & Stroke_Ciraparantag

Let’s continue our series of Future of Drugs. We are now going to take you through the new drugs that are being developed and those that might actually get approved against the rising incidence of Heart Diseases and Stroke.

Ciraparantag has tremendous potential of competing with anticoagulants like edoxaban, rivaroxaban, dabigatran and apixaban.

Ciraparantag is to be administered IV. 

Drug Name	Ciraparantag
Structure
Drug Code	PER 977
Synonym	Aripazine N,N'-(1,4-piperazinediyldi-3,1-propanediyl)bis[2-amino-5-[(aminoiminomethyl)amino]-, (2S,2'S)-pentanamide
Molecular Formula	C22H48N12O2
Innovator	Perosphere
Condition	Anticoagulant Reversal
Mechanism of Action	Blood coagulation factor modulators; Factor Xa inhibitors
Clinical Phase	II in USA (Fast Track Designation)